We are increasing our geopolitical coverage and a struggling healthcare stock.
We are expanding our only oil reserve and a disadvantaged medical technology company.
health care industry
Ro launches GLP-1 supply tracker to help patients overcome shortages
Zoom in iconArrows pointing outwards Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular…
Why the Walmart, Walgreens and CVS health clinic experiment is having problems
Bobbi Radford showed up at the CVS MinuteClinic in Batavia, Ohio, last Thanksgiving because she was having pain in her…
Two CVS pharmacies join new national pharmacy union
The CVS Pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on…
Eli Lilly's big investment in GLP-1, plus CRM, BBY, FL and COST earnings next week
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
What you need to know about human cases, vaccines.
Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | fake images U.S.…
Eli Lilly invests to increase Mounjaro and Zepbound offering
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
Pfizer announces new cost reduction program
Exterior view of the Pfizer headquarters building in New York City on January 29, 2023. Kena Betancur | Corbis News…
The stock market is again under attack by the Federal Reserve. Plus, the quiet return of Starbucks
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…